UEG Week: New treatment regimen that combines semaglutide may eliminate insulin dependence in patients with type 2 diabetes-PR-Newswire
vineOctober 14, 2024 /PRNewswire/ — Breakthrough research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even prevent eliminate the need for insulin therapy. Thanks to this innovative method, which combines a new course of treatment called ReCET (Re-Cellularization via Electroporation Therapy) … Read more